{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T18:38:11Z","timestamp":1776796691918,"version":"3.51.2"},"reference-count":56,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.imbio.2022.152324","type":"journal-article","created":{"date-parts":[[2022,12,30]],"date-time":"2022-12-30T02:17:53Z","timestamp":1672366673000},"page":"152324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein\/Hippo signaling pathway"],"prefix":"10.1016","volume":"228","author":[{"given":"Tao","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.imbio.2022.152324_b0005","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.2174\/0929867322666150812145435","article-title":"Quercetin in cancer treatment, alone or in combination with conventional therapeutics?","volume":"22","author":"Brito","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.imbio.2022.152324_b0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.trecan.2019.04.001","article-title":"Hippo pathway in cancer: aberrant regulation and therapeutic opportunities","volume":"5","author":"Calses","year":"2019","journal-title":"Trends Cancer"},{"key":"10.1016\/j.imbio.2022.152324_b0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.phymed.2018.03.040","article-title":"Reversal effect of quercetin on multidrug resistance via FZD7\/\u03b2-catenin pathway in hepatocellular carcinoma cells","volume":"43","author":"Chen","year":"2018","journal-title":"Phytomedicine"},{"issue":"10192","key":"10.1016\/j.imbio.2022.152324_b0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","article-title":"Nasopharyngeal carcinoma","volume":"394","author":"Chen","year":"2019","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.imbio.2022.152324_b0025","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/s41598-020-80198-0","article-title":"Effects of different combined regimens of cisplatin, metformin, and quercetin on nasopharyngeal carcinoma cells and subcutaneous xenografts","volume":"11","author":"Chen","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.imbio.2022.152324_b0030","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0360-3016(98)00092-3","article-title":"Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy","volume":"41","author":"Cheng","year":"1998","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"10022","key":"10.1016\/j.imbio.2022.152324_b0035","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(15)00055-0","article-title":"Nasopharyngeal carcinoma","volume":"387","author":"Chua","year":"2016","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.imbio.2022.152324_b0040","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.190286","article-title":"Long non-coding RNA LINC00346 contributes to cisplatin resistance in nasopharyngeal carcinoma by repressing miR-342-5p","volume":"10","author":"Cui","year":"2020","journal-title":"Open Biol."},{"issue":"1","key":"10.1016\/j.imbio.2022.152324_b0045","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1475-2867-12-34","article-title":"Quercetin-induced inhibition and synergistic activity with cisplatin \u2013 A chemotherapeutic strategy for nasopharyngeal carcinoma cells","volume":"12","author":"Daker","year":"2012","journal-title":"Cancer Cell Int."},{"issue":"9","key":"10.1016\/j.imbio.2022.152324_b0050","doi-asserted-by":"crossref","first-page":"6544","DOI":"10.1002\/jcp.26595","article-title":"Quercetin: A functional dietary flavonoid with potential chemo-preventive properties in colorectal cancer","volume":"233","author":"Darband","year":"2018","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.imbio.2022.152324_b0055","doi-asserted-by":"crossref","first-page":"645","DOI":"10.7150\/ijms.23460","article-title":"Verteporfin inhibits YAP-induced bladder cancer cell growth and invasion via Hippo signaling pathway","volume":"15","author":"Dong","year":"2018","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.imbio.2022.152324_b0060","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13014-015-0377-9","article-title":"Concurrent chemoradiotherapy was associated with a higher severe late toxicity rate in nasopharyngeal carcinoma patients compared with radiotherapy alone: a meta-analysis based on randomized controlled trials","volume":"10","author":"Du","year":"2015","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.imbio.2022.152324_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117463","article-title":"A review on anti-cancer properties of Quercetin in breast cancer","volume":"248","author":"Ezzati","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.imbio.2022.152324_b0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nano.2019.03.011","article-title":"Chemosensitization and mitigation of Adriamycin-induced cardiotoxicity using combinational polymeric micelles for co-delivery of quercetin\/resveratrol and resveratrol\/curcumin in ovarian cancer","volume":"19","author":"Fatease","year":"2019","journal-title":"Nanomedicine"},{"issue":"6","key":"10.1016\/j.imbio.2022.152324_b0075","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1002\/hep.30961","article-title":"The tumor suppressor interferon regulatory factor 2 binding protein 2 regulates hippo pathway in liver cancer by a feedback loop in mice","volume":"71","author":"Feng","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.imbio.2022.152324_b0080","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.2147\/DDDT.S172538","article-title":"Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth","volume":"12","author":"Gallardo","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"issue":"15","key":"10.1016\/j.imbio.2022.152324_b0085","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"issue":"42","key":"10.1016\/j.imbio.2022.152324_b0090","doi-asserted-by":"crossref","first-page":"6801","DOI":"10.1038\/s41388-019-0924-1","article-title":"The Hippo pathway modulates resistance to BET proteins inhibitors in lung cancer cells","volume":"38","author":"Gobbi","year":"2019","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.imbio.2022.152324_b0095","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12967-019-1869-4","article-title":"Analysis of the role of the Hippo pathway in cancer","volume":"17","author":"Han","year":"2019","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.imbio.2022.152324_b0100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrc3458","article-title":"The Hippo pathway and human cancer","volume":"13","author":"Harvey","year":"2013","journal-title":"Nat. Rev. Cancer"},{"issue":"32","key":"10.1016\/j.imbio.2022.152324_b0105","doi-asserted-by":"crossref","first-page":"52333","DOI":"10.18632\/oncotarget.13775","article-title":"Positive regulation of TAZ expression by EBV-LMP1 contributes to cell proliferation and epithelial-mesenchymal transition in nasopharyngeal carcinoma","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.imbio.2022.152324_b0110","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.21873\/anticanres.14469","article-title":"Quercetin Suppresses Proliferation of Liver Cancer Cell Lines In Vitro","volume":"40","author":"Hisaka","year":"2020","journal-title":"Anticancer Res."},{"issue":"11","key":"10.1016\/j.imbio.2022.152324_b0115","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1002\/hed.26378","article-title":"Global, regional, and national burden of nasopharyngeal carcinoma from 1990 to 2017-Results from the Global Burden of Disease Study 2017","volume":"42","author":"Hu","year":"2020","journal-title":"Head Neck"},{"issue":"4","key":"10.1016\/j.imbio.2022.152324_b0120","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.sjbs.2016.11.011","article-title":"Inhibition of EGF expression and NF-\u03baB activity by treatment with quercetin leads to suppression of angiogenesis in nasopharyngeal carcinoma","volume":"25","author":"Huang","year":"2018","journal-title":"Saudi J. Biol. Sci."},{"issue":"8","key":"10.1016\/j.imbio.2022.152324_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/nu10081021","article-title":"Anti-cancer natural products and their bioactive compounds inducing ER stress-mediated apoptosis: a review","volume":"10","author":"Kim","year":"2018","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.imbio.2022.152324_b0130","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jfda.2019.07.001","article-title":"Quercetin facilitates cell death and chemosensitivity through RAGE\/PI3K\/AKT\/mTOR axis in human pancreatic cancer cells","volume":"27","author":"Lan","year":"2019","journal-title":"J. Food Drug Anal."},{"issue":"6","key":"10.1016\/j.imbio.2022.152324_b0135","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.1016\/j.cllc.2015.05.006","article-title":"Quercetin enhances chemosensitivity to gemcitabine in lung cancer cells by inhibiting heat shock protein 70 expression","volume":"16","author":"Lee","year":"2015","journal-title":"Clin. Lung Cancer"},{"key":"10.1016\/j.imbio.2022.152324_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2019.101890","article-title":"Management of locally recurrent nasopharyngeal carcinoma","volume":"79","author":"Lee","year":"2019","journal-title":"Cancer Treat. Rev."},{"issue":"17","key":"10.1016\/j.imbio.2022.152324_b0145","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1080\/15384101.2017.1356508","article-title":"Hippo pathway contributes to cisplatin resistant-induced EMT in nasopharyngeal carcinoma cells","volume":"16","author":"Li","year":"2017","journal-title":"Cell Cycle"},{"issue":"8","key":"10.1016\/j.imbio.2022.152324_b0150","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1002\/ptr.6081","article-title":"Quercetin reversed MDR in breast cancer cells through down-regulating P-gp expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation","volume":"32","author":"Li","year":"2018","journal-title":"Phytother. Res."},{"issue":"4","key":"10.1016\/j.imbio.2022.152324_b0155","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s12192-019-01008-9","article-title":"Hippo\/Mst1 overexpression induces mitochondrial death in head and neck squamous cell carcinoma via activating \u03b2-catenin\/Drp1 pathway","volume":"24","author":"Ma","year":"2019","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.imbio.2022.152324_b0160","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","article-title":"The hippo pathway: biology and pathophysiology","volume":"88","author":"Ma","year":"2019","journal-title":"Annu. Rev. Biochem"},{"key":"10.1016\/j.imbio.2022.152324_b0165","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.pharmthera.2017.12.011","article-title":"The Hippo pathway in normal development and cancer","volume":"186","author":"Maugeri-Sacc\u00e0","year":"2018","journal-title":"Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.imbio.2022.152324_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.274027.115","article-title":"Mechanisms of Hippo pathway regulation","volume":"30","author":"Meng","year":"2016","journal-title":"Genes Dev."},{"issue":"1\u20132","key":"10.1016\/j.imbio.2022.152324_b0175","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0891-5849(98)00167-1","article-title":"Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product","volume":"26","author":"Metodiewa","year":"1999","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.imbio.2022.152324_b0180","doi-asserted-by":"crossref","first-page":"642","DOI":"10.15252\/embr.201438638","article-title":"The Hippo signaling pathway in stem cell biology and cancer","volume":"15","author":"Mo","year":"2014","journal-title":"EMBO Rep."},{"issue":"3","key":"10.1016\/j.imbio.2022.152324_b0185","first-page":"237","article-title":"Targeting the Hippo signalling pathway for cancer treatment","volume":"161","author":"Nakatani","year":"2017","journal-title":"J. Biochem."},{"issue":"2","key":"10.1016\/j.imbio.2022.152324_b0190","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.cell.2018.03.035","article-title":"Oncogenic signaling pathways in the cancer genome atlas","volume":"173","author":"Sanchez-Vega","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.imbio.2022.152324_b0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13048-019-0530-4","article-title":"Quercetin: a natural compound for ovarian cancer treatment","volume":"12","author":"Shafabakhsh","year":"2019","journal-title":"J. Ovarian Res."},{"issue":"12","key":"10.1016\/j.imbio.2022.152324_b0200","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/2211-5463.12135","article-title":"Down-regulation of miR-26b induces cisplatin resistance in nasopharyngeal carcinoma by repressing JAG1","volume":"6","author":"Shi","year":"2016","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.imbio.2022.152324_b0205","doi-asserted-by":"crossref","unstructured":"Subramaniam, S., K.R. Selvaduray, and A.K. Radhakrishnan, Bioactive Compounds: Natural Defense Against Cancer? Biomolecules, 2019. 9(12).","DOI":"10.3390\/biom9120758"},{"issue":"1","key":"10.1016\/j.imbio.2022.152324_b0210","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1186\/s12885-019-5832-9","article-title":"Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt\/\u03b2-catenin pathway","volume":"19","author":"Tang","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.imbio.2022.152324_b0215","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cbi.2019.01.008","article-title":"Quercetin inhibits human metastatic ovarian cancer cell growth and modulates components of the intrinsic apoptotic pathway in PA-1 cell line","volume":"300","author":"Teekaraman","year":"2019","journal-title":"Chem. Biol. Interact."},{"issue":"9","key":"10.1016\/j.imbio.2022.152324_b0220","doi-asserted-by":"crossref","first-page":"e12887","DOI":"10.1111\/cpr.12887","article-title":"The crosstalk between lncRNAs and the Hippo signalling pathway in cancer progression","volume":"53","author":"Tu","year":"2020","journal-title":"Cell Prolif."},{"issue":"13","key":"10.1016\/j.imbio.2022.152324_b0225","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.2174\/1871520619666190705150214","article-title":"Quercetin loaded nanoparticles in targeting cancer: recent development","volume":"19","author":"Vinayak","year":"2019","journal-title":"Anticancer Agents Med Chem."},{"issue":"5","key":"10.1016\/j.imbio.2022.152324_b0230","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.celrep.2018.10.001","article-title":"Comprehensive molecular characterization of the hippo signaling pathway in cancer","volume":"25","author":"Wang","year":"2018","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.imbio.2022.152324_b0235","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/iub.2242","article-title":"Quercetin radiosensitizes non-small cell lung cancer cells through the regulation of miR-16-5p\/WEE1 axis","volume":"72","author":"Wang","year":"2020","journal-title":"IUBMB Life"},{"key":"10.1016\/j.imbio.2022.152324_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111442","article-title":"Targeted delivery of quercetin by nanoparticles based on chitosan sensitizing paclitaxel-resistant lung cancer cells to paclitaxel","volume":"119","author":"Wang","year":"2021","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"1","key":"10.1016\/j.imbio.2022.152324_b0245","first-page":"585","article-title":"Downregulation of YAP inhibits proliferation, invasion and increases cisplatin sensitivity in human hepatocellular carcinoma cells","volume":"16","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.imbio.2022.152324_b0250","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40880-017-0257-9","article-title":"Nasopharyngeal carcinoma incidence and mortality in China, 2013","volume":"36","author":"Wei","year":"2017","journal-title":"Chin. J. Cancer"},{"issue":"4","key":"10.1016\/j.imbio.2022.152324_b0255","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","article-title":"Hippo pathway in organ size control, tissue homeostasis, and cancer","volume":"163","author":"Yu","year":"2015","journal-title":"Cell"},{"issue":"10054","key":"10.1016\/j.imbio.2022.152324_b0260","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1016\/S0140-6736(16)31388-5","article-title":"Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial","volume":"388","author":"Zhang","year":"2016","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.imbio.2022.152324_b0265","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma","volume":"381","author":"Zhang","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.imbio.2022.152324_b0270","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11596-008-0333-0","article-title":"Effect of quercetin on proliferation and apoptosis of human nasopharyngeal carcinoma HEN1 cells","volume":"28","author":"Zhang","year":"2008","journal-title":"J. Huazhong Univ. Sci. Technolog. Med. Sci."},{"issue":"14","key":"10.1016\/j.imbio.2022.152324_b0275","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1101\/gad.1664408","article-title":"TEAD mediates YAP-dependent gene induction and growth control","volume":"22","author":"Zhao","year":"2008","journal-title":"Genes Dev."},{"issue":"32","key":"10.1016\/j.imbio.2022.152324_b0280","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1038\/s41388-019-0858-7","article-title":"The MRVI1-AS1\/ATF3 signaling loop sensitizes nasopharyngeal cancer cells to paclitaxel by regulating the Hippo-TAZ pathway","volume":"38","author":"Zhu","year":"2019","journal-title":"Oncogene"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298522001504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298522001504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:50:54Z","timestamp":1759251054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298522001504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":56,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0171298522001504"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2022.152324","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quercetin acts as a novel anti-cancer drug to suppress cancer aggressiveness and cisplatin-resistance in nasopharyngeal carcinoma (NPC) through regulating the yes-associated protein\/Hippo signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2022.152324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"152324"}}